Weller J, Zeyen T, Schafer N, Schaub C, et al. The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial. J Neurooncol 2023 Oct 3. doi: 10.1007/s11060-023-04470.
PMID: 37787906